Broadwood Partners, STAAR's largest shareholder, opposes the Alcon merger, citing board conflicts and rushed decision-making.

The special meeting to vote on the company's $1.5 billion sale to Alcon, originally scheduled for today, has been adjourned ...

Millions of contact lens wearers navigating busy schedules and long hours on screens are seeking a balance of comfort and ...

The hotly contested sale of STAAR Surgical Company (NASDAQ:STAA) is under growing scrutiny as the company postponed its shareholder meeting originally set for October 23, where investors were set to ...

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. The research service ...

ISS is now the third proxy advisory firm to urge Staar Surgical shareholders to reject the upcoming $1.5 billion sale to ...

Alcon Inc. (NYSE:ALC) is one of the Best Beaten Down Stocks to Buy According to Hedge Funds. On October 13, BTIG reduced the ...

Please provide your email address to receive an email when new articles are posted on . Alcon will buy Lensar’s outstanding shares for $14 per share. The deal is expected to close in the second half ...

STAAR responded by saying, “We urge all STAAR stockholders not to be misled by Broadwood. STAAR is confident that the Alcon transaction maximizes value for STAAR stockholders [and] is the only merger ...

Alcon has experienced robust Q1 growth, driven by double-digit growth in vision care, particularly in the contact lens market. The company's strong revenue growth is attributed to successful product ...

Alcon Laboratories, already one of the largest employers and taxpayers in Tarrant County, is exploring a major expansion of its Fort Worth campus. Alcon, which started in Fort Worth and has grown to ...

A judge overseeing the bankruptcy of “Matrix” studio Village Roadshow said he’ll issue a ruling shortly on the proposed sale ...